These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29458577)

  • 1. A Novel Delivery Method of Cyclovirobuxine D for Brain-Targeting: Chitosan Coated Nanoparticles Loading Cyclovirobuxine D by Intranasal Administration.
    Wei H; Lai S; Wei J; Yang L; Jiang N; Wang Q; Yu Y
    J Nanosci Nanotechnol; 2018 Aug; 18(8):5274-5282. PubMed ID: 29458577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration.
    Wei H; Liu T; Jiang N; Zhou K; Yang K; Ning W; Yu Y
    J Biomed Nanotechnol; 2018 Jul; 14(7):1252-1262. PubMed ID: 29944099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 4. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
    J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
    Javia A; Thakkar H
    J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X; Chi N; Tang X
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS; Farid RM; ElGamal SS
    Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S; Ho PC
    J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
    Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
    Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives.
    Hassan RH; Gad HA; El-Din SB; Shaker DS; Ishak RAH
    Int J Pharm; 2022 Nov; 628():122278. PubMed ID: 36243325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
    Belgamwar A; Khan S; Yeole P
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):374-386. PubMed ID: 28423949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.
    Elnaggar YS; Etman SM; Abdelmonsif DA; Abdallah OY
    J Pharm Sci; 2015 Oct; 104(10):3544-56. PubMed ID: 26147711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
    Zhang X; Liu L; Chai G; Zhang X; Li F
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
    Hard SAAA; Shivakumar HN; Redhwan MAM
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.